Companies researching Lynparza (Olaparib)
Lynparza (olaparib) is a PARP‑inhibitor medication used as maintenance therapy for adults with advanced ovarian cancer that carries a BRCA mutation.
12
companies
List of companies that research Lynparza (Olaparib)
This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

Employees77kPharmaceutical Manufacturing
Lynparza (Olaparib)Low confidence
Employees1.6kRevenue$35MResearch Services
Lynparza (Olaparib)Low confidence
Employees11kRevenue$716MHigher Education
Lynparza (Olaparib)Low confidence
Employees40kRevenue$10BPharmaceutical Manufacturing
Lynparza (Olaparib)Low confidence
Showing top companies out of 12 that research Lynparza (Olaparib). Get the full list on TheirStack.
Frequently asked questions